Uroflo 0.4 mg (Capsule (Modified Release))
Unit Price: ৳ 10.00 (3 x 10: ৳ 300.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Tamsulosin hydrochloride |
Company | Beximco pharmaceuticals ltd |
Indications
- Treatment of functional symptoms of Benign Prostatic Hyperplasia (BPH)
Pharmacology
- Selective alpha1 adrenoceptor blocking agent
- Relaxes smooth muscle in bladder neck and prostate
- Improves urine flow rate
- Reduces symptoms of BPH
- Absorption of Tamsulosin hydrochloride capsule 0.4mg is essentially complete (90%)
- Time to maximum concentration (Tmax) is reached by four to five hours under fasting conditions
- Extensively metabolized by cytochrome P 450 enzymes in the liver
- Elimination half-life of Tamsulosin hydrochloride in plasma ranges from five to seven hours
Dosage & Administration
- Tamsulosin Hydrochloride 0.4 mg (one capsule) daily, to be taken after meal at night
- Dosage may be increased after 2 to 4 weeks, if necessary
- Capsule should be swallowed whole with a glass of water (about 150 ml) in the standing or sitting position
Interaction
- Concurrent administration of other alfa1-adrenoceptor antagonists could lead to hypotensive effects
- No interactions seen when given concomitantly with atenolol, enalapril, or nifedipine
- Concomitant cimetidine brings about a rise and frusemide a fall in plasma levels of Uroflo
- Diclofenac and warfarin may increase the elimination rate of Uroflo
Contraindications
- Hypersensitivity to Tamsulosin hydrochloride
- History of orthostatic hypotension
- Severe hepatic insufficiency
Side Effects
- Dizziness
- Abnormal ejaculation
- Headache
- Asthenia
- Postural hypotension
- Palpitations
Pregnancy & Lactation
- Not recommended for use
Precautions & Warnings
- Transient postural symptoms have occurred during orthostatic provocation testing after the first dose
- Use in patients with micturition syncope is not advised
- Effects on ability to drive and use machines
Overdose Effects
- Acute hypotension likely to occur after overdosage
- Cardiovascular support should be given
- Renal function should be monitored
- General supportive measures should be applied
- Dialysis is unlikely to be of help
Therapeutic Class
- BPH/ Urinary retention/ Urinary incontinence
Storage Conditions
- Store in a cool and dry place, below 30°C, protected from light
Related Brands
- Urolosin 0.4 mg (Tablet) - general-pharmaceuticals-ltd
- Uromax 0.4 mg (Capsule (Modified Release)) - unimed-unihealth-pharmaceuticals-ltd
- Uropass 0.4 mg (Capsule (Modified Release)) - acme-laboratories-ltd
- Urosin 0.4 mg (Capsule (Modified Release)) - eskayef-pharmaceuticals-ltd
- Urotam 0.4 mg (Capsule (Modified Release)) - navana-pharmaceuticals-ltd